Cart
sales@molnova.com
AN-2690
CAS No. 174671-46-6
AN-2690( Tavaborole | AN2690 | AN 2690 )
Catalog No. M12647 CAS No. 174671-46-6
An antifungal compound that inhibits cytoplasmic leucyl-tRNA synthetase for the potential treatment of nnychomycosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 38 | In Stock |
|
| 25MG | 49 | In Stock |
|
| 50MG | 52 | In Stock |
|
| 100MG | 59 | In Stock |
|
| 200MG | 75 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAN-2690
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn antifungal compound that inhibits cytoplasmic leucyl-tRNA synthetase for the potential treatment of nnychomycosis.
-
DescriptionAn antifungal compound that inhibits cytoplasmic leucyl-tRNA synthetase for the potential treatment of nnychomycosis; inhibits T. rubrum, T. mentagrophytes, C. albicans, C. neoformans with MIC50s of 0.25-1ug/mL.(In Vitro):Tavaborole (AN-2690) shows an 8-fold increase in activity against C. neoformans, and an 8-fold increase in activity against A. fumigatus. Tavaborole (AN-2690) obviously inhibit the cells expressing GlLeuRS-D444A, but has no effect on the cells expressing GlLeuRS and GlLeuRS-D444E.
-
In VitroTavaborole (AN-2690) shows an 8-fold increase in activity against C. neoformans, and an 8-fold increase in activity against A. fumigatus. Tavaborole (AN-2690) obviously inhibit the cells expressing GlLeuRS-D444A, but has no effect on the cells expressing GlLeuRS and GlLeuRS-D444E.
-
In Vivo——
-
SynonymsTavaborole | AN2690 | AN 2690
-
PathwayMicrobiology/Virology
-
TargetFungal
-
RecptorAntifungle
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number174671-46-6
-
Formula Weight151.9307
-
Molecular FormulaC7H6BFO2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESOB1OCC2=CC(F)=CC=C12
-
Chemical Name2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Baker SJ, et al. J Med Chem. 2006 Jul 27;49(15):4447-50.
2. Rock FL, et al. Science. 2007 Jun 22;316(5832):1759-61.
3. Sarkar J, et al. FEBS Lett. 2011 Oct 3;585(19):2986-91.
molnova catalog
related products
-
Cerulenin
An antifungal antibiotic that inhibits fatty acid synthase (FASN), also blocks cellular proliferation of KRAS-associated lung cancer cells.
-
Lanoconazole
Lanoconazole is a potent and orally active imidazole antifungal agent, shows a broad spectrum of activity against fungi in vitro and in vivo.
-
Butenafine hydrochlo...
A synthetic benzylamine antifungal that inhibits the synthesis of ergosterol by inhibiting squalene epoxidase.
